One of Monte Rosa Therapeutics' main differentiating factors is its proprietary QuEEN platform to design new molecular glue degraders. This process also leverages AI. They now have two important ...

Roche seems determined to develop a commanding position in the emerging molecular glue category, signing up to a $2 billion partnership with Monte Rosa Therapeutics that includes a $50 million ...

The lengthening list of pharma alliances focused on molecular glue degraders has another entry after Novartis signed a deal with Monte Rosa Therapeutics worth up to $2.2 billion. The partnership ...

MAN Energy Solutions Schweiz AG and ETH Zurich are forming a strategic partnership to support postdoctoral researchers in the field of sector coupling and energy models. The aim is to analyse European ...

After hours: February 18 at 6:21:06 PM EST ...

The IMF counts “general government debt” as a country’s national debt. By that organization’s standards, at the end of 2020, the gross national debt of Switzerland was 48.7% as a proportion of the ...

Parents need to know that The Count of Monte Cristo is a French-language epic (subtitled in English for U.S. release) adapted from Alexandre Dumas' classic novel. It's long (three hours!), but so is ...